Cherri Miner

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial
    Cherri Miner
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Clin Ther 24:417-33. 2002
  2. ncbi Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries
    Lee S Cohen
    Perinatal Psychiatry Clinical Research Program, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
    Obstet Gynecol 100:435-44. 2002

Detail Information

Publications2

  1. ncbi Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial
    Cherri Miner
    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Clin Ther 24:417-33. 2002
    ..Because the symptoms of premenstrual dysphoric disorder (PMDD) are limited to the luteal phase of the menstrual cycle, the potential benefit of luteal-phase dosing has been hypothesized...
  2. ncbi Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries
    Lee S Cohen
    Perinatal Psychiatry Clinical Research Program, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
    Obstet Gynecol 100:435-44. 2002
    ..To evaluate premenstrual daily dosing with fluoxetine for treatment of premenstrual dysphoric disorder...